Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379024 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms
A Early Phase 1 study, sponsored by Carol Fabian, MD.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT04379024 is a Early Phase 1 study that was terminated before completion, run by Carol Fabian, MD. The registered enrollment target is 11 participants.
The verdict
NCT04379024, a Early Phase 1 study, was terminated before completion, sponsored by Carol Fabian, MD.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Pilot study to test feasibility of 6 months of Duavee® vs wait-list control in post-menopausal women symptomatic for hot flashes.
Interventions
- DRUG DUAVEE 0.45Mg-20Mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-07-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04379024
The ClinicalTrials.gov registry entry for NCT04379024 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carol Fabian, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DUAVEE 0.45Mg-20Mg Tablet is the first listed.
NCT04379024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04379024 about?
NCT04379024 is a clinical study titled "Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms". Pilot study to test feasibility of 6 months of Duavee® vs wait-list control in post-menopausal women symptomatic for hot flashes.
What is the current status of trial NCT04379024?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2020-06-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04379024?
The interventions under investigation include: DUAVEE 0.45Mg-20Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT04379024?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.